Postprandial production of GLP-1 increases insulin secretion from pancreatic beta cells and suppresses glucagon secretion from pancreatic alpha cells
Some medication (like Zepbound) arrives in single use vials that must be discarded after first use
The gut microbiome influences many aspects of metabolic health including digestive signaling, short-chain fatty acid production, immune communication, and gut barrier integrity
Semaglutide remains in the body for several weeks after the last dose, and animal studies showed potential fetal risks
197,239,240 However, one study demonstrated that 24 weeks of exenatide administration did not influence lipid levels
Additionally, the duration for which an individual remains on semaglutide GLP-1 therapy will affect the total cost of treatment